Avid Bioservices 

$10.63
15
+$0.07+0.66% Friday 20:00

统计数据

当日最高
10.96
当日最低
10.42
52周最高
12.48
52周最低
4.07
成交量
381,351
平均成交量
1,006,965
市值
672.4M
市盈率
-
股息收益率
-
股息
-

即将到来

收益

3Dec预期
Q1 2023
Q2 2023
Q3 2023
Q1 2024
Q2 2024
Q2 2024
下一个
-1.94
-1.28
-0.62
0.04
预期每股收益
-0.1175
实际每股收益
N/A

人们还关注

此列表基于关注CDMO的Stock Events用户的观察列表。这不是投资建议。

竞争者

这个列表是基于最近市场事件的分析。这不是投资建议。

分析师评级

12$平均价格目标
最高估值为 $12。
来自过去6个月内的 3 个评级。这不是投资建议。
买入
67%
持有
33%
卖出
0%

关于

Health Technology
Medical Specialties
Biotechnology
Manufacturing
Pharmaceutical Preparation Manufacturing
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant proteins; and offers services, including CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submission and support. It also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, testing, and characterization. The company serves biotechnology and biopharmaceutical industries. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was incorporated in 1981 and is headquartered in Tustin, California.
Show more...
首席执行官
Richard Hancock
员工
371
国家
US
ISIN
US05368M1062

上市公司